Session

Cystectomy: Optimising perioperative care

Poster Session 41

  • Location:
    Room Stockholm (Hall B2, level 0)
  • Chairs:
     J.L. Boormans, Rotterdam (NL)
     O. Rodriguez Faba, Barcelona (ES)
     A.R. Zlotta, Toronto (CA)
  • Aims and objectives of this session

    Understand how to judge risks and how to minimise them in patients undergoing cystectomy.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
508
The impact of cigarette smoking and smoking cessation on oncological aggressiveness at radical cystectomy – a prospective, European, multicenter study of the EAU Young Academic Urologists (YAU) bladder cancer working group

By: Gild P.1, Schmid M.1, Cumberbatch M.2, Dobruch J.3, Gontero P.4, Mertens L.S.5, Necchi A.6, Noon A.2, Preto M.4, Van Rhijn B.5, Roupret M.7, Seiler R.8, Seisen T.7, Shariat S.F.9, Aziz A.1, Chun F.K.1, Xylinas E.10, Rink M.1

Institutes: 1University Medical Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany, 2Sheffield Teaching Hospitals NHS Trust, Dept. of Urology, Sheffield, United Kingdom, 3Centre of Postgraduate Medical Education, Dept. of Urology, Warsaw, Poland, 4University of Turin, Dept. of Surgical Sciences, Urology Clinic, Turin, Italy, 5Netherlands Cancer Institute – Antoni Van Leeuwenhoek Hospital, Dept. of Urology, Amsterdam, The Netherlands, 6National Cancer Institute, Dept. of Medical Oncology, Milan, Italy, 7Hôpital Pitié-Salpétrière, AP-HP, Université Paris 6, Dept. of Urology, Paris, France, 8University Hospital Berne, Dept. of Urology, Berne, Switzerland, 9Medical University Vienna, Dept. of Urology, Vienna, Austria, 10Cochin Hospital, Paris Descartes University, Dept. of Urology, Paris, France

509
Simplified Charlson Comorbidity Index for assessment of perioperative mortality after radical cystectomy

By: Dell’Oglio P.1, Tian Z.2, Leyh-Bannurah S-R.3, Larcher A.4, Moschini M.4, Gandaglia G.4, Fossati N.4, Suardi N.4, Capitanio U.4, Briganti A.4, Montorsi F.4, Karakiewicz P.1

Institutes: 1Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Dept. of Urology, Montreal, Canada, 2McGill University, Dept. of Epidemiology, Biostatistics and Occupational Health, Montreal, Canada, 3Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany, 4Ircss Ospedale San Raffaele, Division of Oncology, Unit of Urology, URI, Milan, Italy

510
An easily applicable single condition-based mortality index for patients undergoing radical cystectomy or radical prostatectomy

By: Fröhner M.1, Koch R.2, Heberling U.1, Novotny V.1, Hübler M.3, Wirth M.1

Institutes: 1Technical University Dresden, Dept. of Urology, Dresden, Germany, 2Technical University Dresden, Dept. of Medical Informatics, Dresden, Germany, 3Technical University Dresden, Dept. of Anaesthesiology, Dresden, Germany

511
Preoperative systemic inflammation may predict severe complications after radical cystectomy

By: Ryndzin A., Rolevich A., Minich A., Zelenkevich I., Polyakov S., Krasny S., Sukonko O.

Institutes: N.N. Alexandrov National Cancer Center, Dept. of Urology, Minsk, Belarus

512
The choice of perioperative crystalloid solution enhances recovery of gastrointestinal function after radical cystectomy: Results of a randomized clinical trial

By: Loeffel L.M.1, Burkhard F.C.2, Wüthrich P.Y.1

Institutes: 1University Hospital Berne, Dept. of Anesthesiology and Pain Medicine, Berne, Switzerland, 2University Hospital Berne, Dept. of Urology, Berne, Switzerland

513
Sarcopenia as a novel preoperative prognostic predictor for survival in patients with bladder cancer undergoing radical cystectomy

By: Hirasawa Y., Nakashima J., Tatsuo G., Shimizu Y., Tokuyama N., Shimodaira K., Nakagami Y., Horiguchi Y., Ohno Y., Namiki K., Ohori M., Tachibana M.

Institutes: Tokyo Medical University, Dept. of Urology, Tokyo, Japan

514
Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for non-metastatic bladder cancer: Results from a single high-volume institution

By: Moschini M.1, Gandaglia G.1, Cucchiara V.1, Burgio G.1, Mattei A.2, Shariat S.3, Cantiello F.4, Damiano R.4, Salonia A.1, Briganti A.1, Montorsi F.1, Colombo R.1, Gallina A.1

Institutes: 1Uri, Irccs San Raffaele Scientific Institute, Dept. of Oncology and Urology, Milan, Italy, 2Luzerner Kantonsspital, Dept. of Urology, Lucerne, Switzerland, 3Medical University of Vienna, Dept. of Urology, Vienna, Austria, 4Magna Graecia University of Catanzaro, Doctorate Research Program, Catanzaro, Italy

515
Does postoperative parenteral nutrition after radical cystectomy impact oncological and functional outcomes in bladder cancer patients?

By: Vidal Faune A., Arnold N., Vartolomei M., Kiss B., Burkhard F.C., Thalmann G.N., Roth B.

Institutes: University Hospital Berne, Dept. of Urology, Berne, Switzerland

516
Hospital but not surgical volume predicts 30- and 90-day complications in radical cystectomy (RC) – results from the prospective multicenter radical cystectomy series (PROMETRICS 2011) study group

By: Meyer C.P.1, Leyh-Bannurah S-R.1, Vetterlein M.W.1, Mayr R.2, Gierth M.2, Fritsche H-M.2, Burger M.2, Keck B.3, Wullich B.3, Martini T.4, Bolenz C.4, Pycha A.5, Hanske J.6, Roghmann F.6, Noldus J.6, Gilfrich C.7, Bastian P.J.8, May M.7, Rink M.1, Chun F.K.H.1, Dahlem R.1, Fisch M.1, Aziz A.1

Institutes: 1University Medical Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany, 2Caritas St. Josef Medical Center, University of Regensburg, Dept. of Urology, Regensburg, Germany, 3University Medical Center Erlangen, Dept. of Urology, Erlangen, Germany, 4University Medical Center Ulm, Dept. of Urology, Ulm, Germany, 5Central Hospital Bolzano, Dept. of Urology, Bolzano, Italy, 6Marienhospital Herne, Ruhr-University Bochum, Dept. of Urology, Herne, Germany, 7St. Elisabeth Medical Center Straubing, Dept. of Urology, Straubing, Germany, 8Paracelsus Medical Center Golzheim, Dept. of Urology, Düsseldorf, Germany

517
Contemporary surgical outcomes of radical cystectomy in a decentralized health system. Does volume matter?

By: Llorente C.1, Hernández V.1, Pérez-Fernández E.2, Elze M.C.3, López B.1, Pocock S.3

Institutes: 1Hospital Universitario Fundación Alcorcón, Dept. of Urology, Madrid, Spain, 2Hospital Universitario Fundación Alcorcón, Dept. of Research , Madrid, Spain, 3London School of Hygiene and Tropical Medicine, Dept. of Medical Statistics, London, United Kingdom

518
Contemporary analysis of comorbid diseases used to define Charlson comorbidity index score among radical cystectomy candidates

By: Dell’Oglio P.1, Tian Z.2, Leyh-Bannurah S-R.3, Larcher A.4, Moschini M.4, Trudeau V.1, Capitanio U.4, Briganti A.4, Montorsi F.4, Karakiewicz P.1

Institutes: 1Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Dept. of Urology, Montreal, Canada, 2McGill University, Dept. of Epidemiology, Biostatistics and Occupational Health, Montreal, Canada, 3Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany, 4Irccs Ospedale San Raffaele, Dept. of Oncology and Urology, Milan, Italy

519
The impact of a minimum cystectomy volume policy on the centralization and quality of bladder cancer care in the Netherlands

By: Bruins H.M.1, Fransen Van De Putte E.2, Verhoeven R.3, Van Oort I.1, Horenblas S.2

Institutes: 1Radboudumc, Dept. of Urology, Nijmegen, The Netherlands, 2Netherlands Cancer Institute – Antoni Van Leeuwenhoek Hospital, Dept. of Urology, Nijmegen, The Netherlands, 3Comprehensive Cancer Organisation The Netherlands, Nijmegen, The Netherlands